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ECONOMIC ANALYSIS OF A LARGE SCALE ORAL
VACCINATION PROGRAM TO CONTROL RACCOON
RABIES
PHILIP KEMERE, MICHAEL K. LIDDEL, PHYLO EVANGELOU, DENNIS SLATE
AND STEVEN OSMEK
Abstract: Since the late 1980s, results of oral vaccination trials in several states have provided growing evidence that this
vaccination method may be effective for controlling the spread of rabies in raccoons (Procyon lotor). This study examines
the economic feasibility of using oral vaccination on a larger scale than previous trials. We analyze the benefits and costs
associated with a hypothetical barrier that would stretch from Lake Erie to the Gulf of Mexico, combining natural geographic
features provided by the Appalachian Mountains with oral vaccination zones. The goal of this barrier would be to prevent the
raccoon rabies variant from moving west into broader geographic regions of the United States. The costs of establishing and
maintaining this hypothetical barrier are compared to the avoided costs of not having to live with raccoon rabies west of its
current distribution. The westward advance of raccoon rabies, if it is not contained, is projected using simple models based
on constant rates of spread. Our results show that preventing the westward movement of raccoon rabies by combining an
oral vaccination program with natural barriers may be economically feasible. Discounted costs of establishing and maintaining
the barrier are estimated to total between US$58 million and US$148 million. Net benefits of program implementation range
between US$48 million and US$496 million for a variety of models, including ones that exclude forgone pet vaccination
expenditures. The analysis also provides a framework for developing future models to explore the benefits and costs of
eliminating raccoon rabies from currently affected areas.
Key Words: barrier, cost-benefit, economics, oral vaccination, ORV, Procyon lotor, rabies, Raboral V-RG®, raccoon.

Reported cases of animal rabies in the United
States have nearly doubled in the last 30 years, with
most of the increase attributable to the spread of raccoon rabies in the northeastern states. The raccoon epizootic has spread east and north from the Virginia/West
Virginia border and has also converged with raccoon
rabies in the Carolinas (Krebs et al. 1998). In the past
21 years, all of the mid-Atlantic and New England states
have experienced at least one outbreak. The raccoon
rabies epizootic front reached Maine in 1994, reflecting
a movement rate of about 30 to 35 miles per year (48.3
km/yr). It was also first confirmed in northeastern Ohio
in 1996 (Krebs et al. 1998). In 1999, the first three cases
of raccoon rabies were confirmed in southern Ontario
(MacInnes, Ontario Ministry of Natural Resources, pers
com).
Several states and jurisdictions have implemented
oral rabies vaccination (ORV) programs using the
vaccine Raboral V-RGÒ either to attempt to halt the
advance of raccoon rabies or eliminate or reduce it.
These areas include: Pinellas County, Florida; Cape Cod,
Massachusetts; Cape May, New Jersey; portions of New
York, Vermont and Ohio, and recently, Anne Arundel
County, Maryland and Fairfax, Virginia. In addition,
Raboral V-RGÒ has been used with success to control
rabies in coyotes (Fearneyhough et al. 1998) and gray
foxes in Texas (Fearneyhough and Wilson 2000). Data
from these site-specific programs provide a basis for
considering larger scale control efforts.
Raccoon rabies presents a human health threat
though potential direct exposure to rabid raccoons, or
indirectly through the exposure of a pet to rabid rac-

coons. To date, there have been no known cases of
rabies in humans attributable to raccoon rabies. However, the number of pets and livestock examined and
vaccinated for rabies, the number of tests requested,
and the number of post-exposure treatments are all
greater when raccoon rabies is present. Human and
financial resources allocated to rabies-related human
and animal health needs also increase, often at the
expense of other important activities.
The westward movement of the raccoon rabies
front has slowed, probably in response to both natural
geographic and man-made barriers. The Appalachian
mountains and perhaps river systems flowing eastward
have helped confine the raccoon variant to the eastern
United States. In northeast Ohio, an ORV program has
established an “immune barrier” along its border with
Pennsylvania from the Lake Erie to the Ohio River near
East Liverpool, Ohio that has slowed if not stopped
the westward expansion of raccoon rabies. If raccoon
rabies breaches this barrier, current raccoon live trapping results in Ohio (Montoney, personal communication) as well as the status of raccoons in the Midwest
(Sanderson and Hubert 1982, Glueck et al. 1988, Hasbrouck et al. 1992, Mosillo et al. 1999) suggest that
populations are sufficient for rabies to spread westward
along a front, similar to or more rapidly (Rupprecht and
Smith 1994) than it has in the eastern United States.
For this analysis we refer to two regions of the
United States. The first region consists of the states that
are already affected by raccoon rabies (epizootic/postepizootic states). These are primarily the mid-Atlantic,
New England, and eastern seaboard states, although
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portions of Florida and Georgia in particular have had
enzootic rabies for 40 to 50 years or more and may be
thought of as post-epizootic states within the affected
eastern US. The second region consists of the Midwest
and Plains states, out to the Rocky Mountains that have
never experienced raccoon variant of rabies (pre-epizootic states).
The presence of the raccoon rabies variant has
been shown to dramatically increase the incidence
of rabies, and may present a higher exposure risk
than other variants. Krebs et al. (1998) reports that
6,563 of the 8,513 reported animal rabies cases in the
United States in 1997 were from states that had experienced raccoon rabies (epizootic/post-epizootic states)
and 1,238 were from states currently unaffected by the
raccoon variant (pre-epizootic states). In both regions,
wild animal infections were dominant. However, there
were more infected domestic cats and dogs reported
in epizootic/post-epizootic states than in pre-epizootic
states. Of the 6,210 wild animal cases reported in epizootic region, 4,276 were raccoon cases. The epizootic
states also reported more skunk, fox, and bat cases than
did the pre-epizootic states.
ASSUMPTIONS
This analysis examines a hypothetical barrier
against the spread of raccoon rabies. Higher elevations
of the Appalachian Mountains are assumed to form portions of this barrier. This assumption is based in large
part on the pattern for raccoon rabies spread from
West Virginia in the late 1970s. From that focus, raccoon rabies moved generally north and east. Presumably
this pattern of spread was due in part to the effect
of poorer raccoon habitats at higher elevations in the
Appalachians which served as natural barriers to the
westerly movement of the disease (Rupprecht and Smith
1994).
In addition, models and results rely heavily on several other basic assumptions. We assume that without
intervention the raccoon rabies variant would spread
westward across the Midwest and Plains states. Ohio
has recently encountered the raccoon rabies variant in
areas near its eastern border, and established an ORV
program to attempt to contain it. Ohio experienced
a breach in its barrier in 1999. The barrier was subsequently widened with no additional cases of raccoon
variant west of the current vaccination barrier (Smith,
personal communication). Also, there has recently been
evidence of raccoon rabies crossing the Alabama River
and entering the western part of Alabama (W. B. Johnston, Alabama Department of Public Health, personal
communication).
The second main assumption is that the consequences of the raccoon rabies variant entering the Midwest and Plains states would be similar to what has
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been experienced by states already affected, despite
demographic and ecological differences between the
affected and unaffected states. As raccoon rabies occupies a broader geographic area, there is an expectation
of greater numbers of rabies cases in other wild and
domestic animals, along with the increase in raccoon
rabies cases. Although the pre-epizootic Midwest and
Plains states collectively have a lower human population
and per capita income, they have a larger land area
and more domestic livestock than the states currently
affected by the raccoon rabies variant. These states also
have the capacity to support abundant raccoon populations (Stuewer 1943, Twitchell and Dill 1949, Urban
1970, Schinner and Gauley 1974, Sanderson and Hubert
1982, Glueck et al. 1988, Hasbrouck et al. 1992, Mosillo
et al. 1999). These factors could affect the movement
of the raccoon rabies variant, and the impact it has
on human populations. However, without specific data
on how the epizootic will spread, we assume that the
impacts will be similar to the states already affected.
Additionally, we assume that current methods of
oral rabies vaccination can effectively contain the raccoon rabies variant. Studies on the effectiveness of ORV
in several states have shown that the methods used
appear to be effective. Specifically, the ORV program
in Ohio against raccoon rabies and the ORV program
in Texas against coyote rabies have had good results
(Fearneyhough et al. 1998, Collart 2000). Implicit in
this assumption is that translocation of a rabid raccoon
into the unaffected areas would not occur, or would not
lead to establishment of the raccoon rabies variant as
was documented in West Virginia in the 1970s (Nettles
et al. 1979).
METHODS
Benefits and costs are monetized in a cost-benefit
framework. Benefits are all costs, including direct medical and nonmedical costs, that would be avoided
as a result of the proposed ORV program. Other
indirect avoided costs such as time lost due to prophylaxis, potential adverse effects of the oral vaccine, business losses due to decreased recreational activities in
affected areas, and the value of potential lost life are not
included. These would all raise the expected benefit.
The benefits result from preventing the adverse
effects of the epizootic, and related expenditures to
manage and control it, in the pre-epizootic states. These
avoided consequences include increased public education regarding raccoon rabies, a larger number of preexposure vaccinations and post-exposure treatments,
increased compliance rates for dog and cat vaccinations,
increased local animal control and surveillance activities, and increased raccoon-focused wildlife management activities. Also, laboratory staff and supply needs
would increase costs.
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Fig. 1. Assumed rabies spread.

The study estimates the benefit of avoiding epizootic expansion as the sum of public and private
expected expenses; that is, costs beyond those currently borne due to the presence of other strains of
rabies. These are quantified in terms of cost savings,
by comparing anticipated epizootic and post-epizootic
costs to pre-epizootic rabies private costs and program
expenditures. The net avoided incremental costs are
then compared with the barrier program costs in deciding whether the program is economically feasible, with
future benefits and costs discounted to present values.
Two rates are assumed for the spread of the epizootic
over a 20-year time horizon: 25 miles/year (40.23km/yr)
and 75 miles/ year (120.7 km/yr) (Fig. 1).
In the analysis, the increase in number of pet vaccinations due to the epizootic is considered a forgone
cost. Although routine pet vaccination is a regulatory
requirement in most of the states considered here, a percentage of pets remains unvaccinated until imminent
danger threatens. From a public health perspective,
the resultant increased compliance as raccoon rabies
becomes established is clearly good from a public health
perspective. However, because these increased resource
requirements would result from the emergency situation and not reflect planned action, these costs are here
considered as private costs. Vaccination of pets is a

major reason why few human deaths from rabies occur
in developed countries and most jurisdictions continuously allocate rabies control resources for pet vaccination services and education.
MODEL
The model that is used has 2 major components.
One component estimates the costs for establishing and
maintaining the barrier, as well as other costs related
to the proposed ORV program. The other component
estimates the costs that would be incurred if raccoon
rabies spread westward unchecked.
Data on the costs associated with the raccoon
rabies variant were collected from a variety of sources
including previous studies (Sherman 1990, Uhaa et al.
1992, Huntley et al. 1995, Meltzer 1996), reference literature (AVMA 1997, Bureau of the Census 1998, CDC
1998, NASS 1998, 1999), direct contacts with people
working with raccoon rabies and oral vaccines, and a
pair of surveys sent out to several state public health
veterinarians. In most cases, multiple sources were used
to determine mean or median values that would be
sufficiently representative of the states included in the
analysis. Where relevant, each element was assigned
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a pre-epizootic value, an epizootic value and a postepizootic value.
Bait, its distribution and project evaluation costs
are provided in Table 1. Program costs are estimated
under the following baseline assumptions. The costs of
potential adverse effects of the oral vaccine program
(nontarget animals affected by consuming baits, accidental human contact with the baits, etc.) are assumed
to be zero. The effectiveness of vaccination programs
would be validated through surveillance and testing of
raccoon populations in the barrier zones (i.e., program
evaluation). The evaluation cost listed also includes educational, promotional, and overhead expenses.
Table 1. Barrier and program costs.
Program cost components

Unit values

Area baited
Bait density
Bait cost (Raboral V-RG®)
Aerial distribution cost
Program evaluation

102,650 km2
75/km2
US$1.30/unit
US$8.62/km2
US$15.00/km2

The cost of the barrier is calculated annually.
However, because the cost of maintaining the barrier is
likely to be less than initial establishment costs, we use
a lower value after the initial period. For the first 5 years
we use the full program cost. This period represents a
higher level of baiting over the entire barrier area.
Every year thereafter we use 40% of the full program
cost. This period represents a lower level of baiting as
the emphasis of the program shifts primarily to monitoring and spot baiting as needed. Total discounted program costs for the planned 20-year time horizon are
US$95,700,000.1
Determining the costs that would be avoided by
establishing an immune barrier is more complex. They
are calculated by estimating the spread of the raccoon
rabies epizootic as a uniform movement from the bar1

For this analysis we use a 7% discount rate as advised by OMB circular
No. A-94 “Guidelines and Discount Rates for Benefit-Cost Analysis of Federal
Programs” Section 8b.

rier location to the Rocky Mountains (Fig. 1). For each
year of the model, a new “slice” of the pre-epizootic
area would be affected. Geographic Information Systems (ESRI, ArcView GIS 3.1) are used to determine
the shape of each “slice” as well as the human population within each of these areas. The cost of raccoon
rabies for each area is determined by its population and
base costs per 100,000 population (Table 2). The total
avoided cost each year is the summation of costs that
would be incurred in currently and previously affected
“slices.”
The data elements used to determine the costs
associated with a raccoon rabies epizootic are the same
as those used by Uhaa et al. (1992): animal-associated
costs, human-associated costs, and other rabies-related
expenditures. The most significant component of the
animal cost category is the increase in pet and livestock
vaccinations in response to a raccoon rabies epizootic.
For dogs, this represents an increase in vaccination rates
from an average of 45% vaccinated under pre-epizootic
conditions, to 65% in epizootic conditions, and down to
60% in post-epizootic conditions. For cats, the vaccination
rate is 23% before the raccoon rabies epizootic, 40%
during the epizootic, and 25% during post-epizootic
years.
For livestock, less than 0.5% are vaccinated before
an epizootic. During an epizootic, vaccination rates are
just over 1%, and they then drop back to less than 1%
during post-epizootic years. For this study all mammalian livestock were counted together, and as a result, the
costs may be somewhat skewed. The livestock figures
are influenced by vaccination costs that are extremely
low for swine, sheep, goats, and cattle, but higher for
horses. Vaccination rates are low, but the mean cost
per head for domestic animals overall is comparable to
the cost of vaccinating a dog or cat. To examine the
significance of avoided pet and livestock vaccination
costs, they are excluded in two model variations.
The other major elements of animal-associated
costs deal with surveillance and monitoring of rabies
in wildlife and domestic animals. These include labora-

Table 2. Incremental costs for the avoided cost components.
Avoided cost
component
Pre-exposure prophylaxis
Post-exposure prophylaxis
Surveillance
Lab costs
Case investigations
Dog vaccinations
Cat vaccinations
Livestock vaccinations
Educational programs
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Incremental epizootic
US$cost/100,000
2,800
32,600
6,300
7,600
6,500
46,000
44,000
10,600
21,400

Incremental postepizootic
US$cost/100,000
900
4,200
4,100
6,800
8,200
35,000
13,000
6,100
21,400

US$cost/unit
300
1.50
n/a
n/a
n/a
10
10
10
n/a
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tory diagnostic costs, the costs of preparing samples
for testing, and animal bite investigations. Survey results
show that the cost for laboratory diagnostics appears
to increase significantly when raccoon rabies enters the
epizootic stage and remains high into the post-epizootic
stage. This may reflect not only larger numbers of animals tested, but also more detailed virus typing and
more sophisticated rabies tests, as part of an overall
more intensive surveillance program.
Other animal-associated costs specified in other
studies include those for domestic animal control and
confinement of domestic animals suspected of having
rabies (Uhaa et al. 1992, Huntley et al. 1995, Meltzer
1996, Masters 1998). These costs are excluded from our
study due to a lack of information about expenditure
levels. Other costs or perhaps benefits not included
in this study are the wildlife conflict costs (e.g., does
raccoon rabies increase or decrease costs of raccoonrelated conflicts with humans?). Also not included
here are damage, nuisance, and predation impacts on
ground-nesting birds. These costs may be expected to
decline as a result of rabies mortality in areas supporting abundant raccoon populations. If this effect does
occur, it is likely to be short-term (1-3 years) until the
local raccoon population recovers. Further study on this
topic is required, including the impacts of the typically
heightened sense of urgency associated with raccoon
problems, independent of raccoon density, when rabies
is documented in a specific geographic area.
Human-associated costs include the cost of preexposure vaccination and post-exposure treatment. In a
rabies epizootic, these costs increase as more people at
risk protect themselves against rabies through pre-exposure vaccinations. Post-exposure prophylaxis increases
as the number of potential and actual exposures to
rabies increases (Meltzer 1996, Kreindel et al. 1998).
Data on the cost and number of human preand post-exposure treatments were gathered primarily
through surveys. Other costs associated with raccoon
rabies include costs for public education, additional
public health staffing, additional staff training, and additional administrative and clerical costs.
The 2 cost structures shown in Table 2 represent
the somewhat cyclical nature of a raccoon rabies epizootic. Typically, when raccoon rabies enters a new area
the epizootic can be intense for a few years, subside
to a lower level, and then re-emerge (Trimarchi 1995,
Meltzer 1996, CDC 1997). To account for this pattern,
the epizootic cost structure is assumed for the first
three years that raccoon rabies is new to an area. Subsequently the “post-epizootic” cost structure is used, with
a switch back to the epizootic structure once every 5
years for a year.
Four model variations were evaluated. We use 25
and 75 miles per year (mpy) for the rates at which the
epizootic spreads westward. Additionally, we evaluated

variations including and excluding the cost of animals
vaccinated in response to the epizootic. Model A uses
25 mpy and includes animal vaccination costs. Model
B uses 25 mpy and excludes animal vaccination costs.
Model C uses 75 mpy and includes animal vaccinations.
Model D uses 75 mpy and excludes animal vaccinations.
RESULTS AND ANALYSIS
Annual avoided costs (benefits) and program
costs are discounted to present values. The final stage of
the analysis involves comparing these discounted benefits and costs. The primary decision criterion is net
benefits or net present value (NPV). NPV is the present
value of benefits (avoided costs) gained minus the present value of program costs incurred. If NPV is positive,
then the ORV program is considered economically feasible.
Net benefits for each of the 4 model variations for
the total discounted program cost of US$95.7 million
are economically feasible (Table 3).
Table 3. Net present values for models evaluated.a
Model
A: 25 mpy advance (40.2 km/yr)
B: 25 mpy advance (40.2 km/yr),
no animal vac.
C: 75 mpy advance (127.1 km/yr)
D: 75 mpy advance (127.1 km/yr),
no animal vac.
a

Net benefit
(US$millions)
202
109
496
313

Discount rate = 7%

To explore some alternative situations and test the
robustness of the models, we conducted several types
of sensitivity analysis. First, we considered a scenario
in which the full program costs are used for the entire
period instead of dropping to 40% after 5 years. In this
case, the total discounted program cost for the planned
time horizon is US$157,320,000. All of the model variations remain economically feasible (Table 4).
Table 4. Net benefits (NPV) with full program cost for
entire time horizon.a
Model
A: 25 mpy advance (40.2 km/yr)
B: 25 mpy advance (40.2 km/yr),
no animal vac.
C: 75 mpy advance (127.1 km/yr)
D: 75 mpy advance (127.1 km/yr),
no animal vac.
a

Net benefit
(US$millions)
141
48
422
259

Discount rate = 7%

We examined the maximum program costs that
the benefit stream would support (Table 5). This is
the program cost at which net benefits are zero. When
113
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compared to the estimated program cost of US$95.7 million, these maximum costs indicated that the program
could be twice as expensive as estimated and remain
economically feasible.
Table 5. Largest ORV program cost that benefits could
support.a
Maximum program cost
(US$millions)

Model

A: 25 mpy advance (40.2 km/yr)
B: 25 mpy advance (40.2 km/yr),
no animal vac.
C: 75 mpy advance (127.1 km/yr)
D: 75 mpy advance (127.1 km/yr),
no animal vac.
a

298
205
586
403

Estimated program cost = US$95.7 million

To determine if the model is sensitive to the discount rate of 7%, net benefits were evaluated for discount rates of 5% and 10% (Table 6). As expected, net
benefits are smaller due to the increased discount rate.
Table 6. Net benefits (NPV) for 5% and 10% discount
rates.
Model
A: 25 mpy advance (40.2 km/yr)
B: 25 mpy advance (40.2 km/yr),
no animal vac.
C: 75 mpy advance (127.1 km/yr)
D: 75 mpy advance (127.1 km/yr),
no animal vac.

NPV 5%
281

NPV 10%
126

160
615

60
367

394

226

Monte Carlo Sensitivity Analysis
The Monte Carlo sampling technique was used to
examine the robustness of model results by simulating
assumed values of relevant parameters. The NPVs were
estimated, running each simulation for 10,000 iterations
using the risk analysis computer package @RISK for
Excel (Palisade Corporation, Newfield, NY). For each
iteration, the program selects input values at random
from the probability distributions specified and estimates the outputs (the discounted costs and NPVs) for
the program period. From this simulated data base, various measures of central tendency and percentiles are
used to alleviate reliance on single point estimates. For

example, the total baited area is expected to range
between 84,500 and 120,800 km2, and this range can
be more confidently applied in a simulation than a point
estimate of 102,650 km2 (Table 7).
Lacking knowledge concerning the shape of the
probability distribution of these input variables, we
used the uniform and the triangular distributions to
define uncertainty. Both of these distributions are
among the simplest means of representing uncertainty.
Uniform distribution is used where one can specify only
the minimum and maximum possible values for the
input variable. Any numerical value is equally likely to
occur within these limits. Triangular distribution is used
to represent the distribution of a random variable when
the most likely value is also known.
The average NPVs over 10,000 trials shown in
Table 8 are close to the base calculations shown in
Table 6. The coefficient of variation is low for all models
tested, ranging between 0.008 and 0.038, indicating
that the estimated values are stable (Table 8). Thus,
the results appear to be robust, and we conclude with
reasonable confidence that net economic benefits, in
terms of avoided costs due to the ORV program, would
be substantial.
Discounted program costs for the base model
range between US$58 million and US$148 million.
The expected cost is about US$95.6 million, while the
median cost is about US$94.7 million. The results are
not particularly sensitive to assumed aerial distribution
costs. Substantially increasing the distribution cost to
US$35 per square kilometer results in a cost range of
between US$57 million and US$165 million, with an
expected cost of about US$105.4 million and a median
cost of US$104.5 million. The differences between these
results and those of the base model are small considering the time period. The NPVs using the US$35 per km2
for distribution costs are US$182 million, US$88.4 million, US$476 million and US$293 million, for models A,
B, C, and D, respectively.
CONCLUSIONS
The models presented indicate that a large scale
ORV program, such as the one proposed, should be economically feasible, given the program costs and avoided

Table 7. Cost components, point estimates, probability distributions and assumed range of values.a
Program cost components

Average values

Probability distribution

Range of values

Barrier area in km
Bait density/km2
Bait cost/unit
Aerial distribution cost/km2
Cost/km2

102,650
75
US$1.30
US$8.62
US$15.00

Uniform
Triangular
Uniform
Uniform
Uniform

84,500-120,800
50-75-100
US$1.20-US$1.40
US$6.92-US$10.32
US$12.00-US$18.00

2

The range of values for the uniform distributions are the minimum and maximum values and those for the triangular
distribution are the minimum, most likely, and maximum.
a
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Table 8. Net Benefits (NPV) using the Monte Carlo Sensitivity Analysis (US$million).a
Model
Minimum
Maximum
Mean
Standard deviation
Estimated value (from Table 3)
a

Model A

Model B

Model C

Model D

185.00
216.00
202.00
4.10
202.00

92.10
123.00
109.00
4.11
109.00

478.00
511.00
496.00
4.07
496.00

298.00
327.00
313.00
4.07
313.00

Discount rate = 7%

cost assumptions. Results of the Monte Carlo analysis,
even when we consider the uncertainty of values, indicate that the program costs remain stable. Avoided costs
are driven mainly by the cost of human post-exposure
prophylaxis and pet vaccinations. Estimates for these
variables are calculated on a per 100,000 human population basis. As such, they depend on the speed that the
raccoon rabies variant moves westward as well as the
pattern and distribution of the westward spread. For
this analysis we have used a uniform distribution and
2 constant spread rates. As more information becomes
available about how the variant might spread westward
it may be possible to add sophistication to our models
and further refine projected ORV program costs and
benefits.
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